KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $72.2 billion.

  • Merck's Retained Earnings rose 1767.07% to $72.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $72.2 billion, marking a year-over-year increase of 1767.07%. This contributed to the annual value of $63.1 billion for FY2024, which is 1702.2% up from last year.
  • As of Q3 2025, Merck's Retained Earnings stood at $72.2 billion, which was up 1767.07% from $68.5 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Retained Earnings ranged from a high of $72.2 billion in Q3 2025 and a low of $48.8 billion during Q2 2021
  • In the last 5 years, Merck's Retained Earnings had a median value of $58.4 billion in 2022 and averaged $58.6 billion.
  • As far as peak fluctuations go, Merck's Retained Earnings skyrocketed by 1980.44% in 2022, and later tumbled by 1176.47% in 2023.
  • Merck's Retained Earnings (Quarter) stood at $53.7 billion in 2021, then rose by 13.75% to $61.1 billion in 2022, then decreased by 11.76% to $53.9 billion in 2023, then grew by 17.02% to $63.1 billion in 2024, then grew by 14.53% to $72.2 billion in 2025.
  • Its Retained Earnings stands at $72.2 billion for Q3 2025, versus $68.5 billion for Q2 2025 and $66.1 billion for Q1 2025.